Schroeder Theodore R

Schroeder Theodore R is listed in filings as Director at Phathom Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including 17 public disclosures. Recent filings connect the profile to Phathom Pharmaceuticals, Inc. (PHAT) and Cidara Therapeutics, Inc. (CDTX). The current snapshot covers public activity from Jul 19, 2024 to May 21, 2026. Reported amounts are shown as $467.6K to $92.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.